inhibitor library

A unique collection of 8328 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 1147 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;

A unique collection of 2720 kinase inhibitors regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

A unique collection of 263 kinase inhibitors regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 604 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;

A unique collection of 343 protease and proteasome inhibitors for research in chemical genomics, and drug screening;

A unique collection of 485 PPI-related compounds for drug screening;

A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;

A collection of 79 phosphatase inhibitors with known activity;

A unique collection of 1920 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc.

A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;

A collection of 575 highly selective inhibitors

A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;

A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening;

678 hypertension-related small molecules for high-throughput and high-content screening.

A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa